Status:
COMPLETED
Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension
Lead Sponsor:
Daegu Catholic University Medical Center
Collaborating Sponsors:
The Korean Society of Ginseng
Conditions:
Hypertension
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine Korean red ginseng (KRG)treatment could decrease central blood pressure in subjects with hypertension.
Detailed Description
Participants with hypertension who were treated with antihypertensive agents were randomly assigned to an active (KRG 2 g/day) or a placebo treatment group in a double-blind cross over manner. Partic...
Eligibility Criteria
Inclusion
- Essential hypertension
- diastolic blood pressure 100 mmHg or less and systolic blood pressure 160 mmHg or less
Exclusion
- Secondary hypertension
- Serum creatinin above 1.5 mg/dL
- aspartate aminotransferase(AST) and alanine aminotransferaseALT above two times upper normal limits
- Uncontrolled diabetes (Hb A1c \< 9%)
- Acute myocardial infarction or coronary artery disease intervention within six months
- Moderate to severe congestive heart failure
- HIV positive
- Immunocompromized host
- Allergy to Korean red ginseng
- Pregnancy or plan to pregnancy
- Alcohol or drug abuse
- Attend to other clinical trial within 12 weeks
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT02211352
Start Date
May 1 2012
End Date
July 1 2014
Last Update
August 7 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Daegu Catholic University Medical Center
Daegu, South Korea, 705-718